Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels
Open Access
- 23 January 2012
- journal article
- viral hepatitis
- Published by Wolters Kluwer Health in Hepatology
- Vol. 56 (2) , 434-443
Abstract
To evaluate whether hepatitis B virus (HBV) preS/S gene variability has any impact on serum hepatitis B surface antigen (HBsAg) levels and to analyze the replication capacity of naturally occurring preS/S variants, sera from 40 untreated patients with HBV-related chronic liver disease (hepatitis B e antigen [HBeAg]-positive, n = 11; HBeAg-negative, n = 29) were virologically characterized. Additionally, phenotypic analysis of three different preS/S variant isolates (carrying a 183-nucleotide deletion within the preS1 region, the deletion of preS2 start codon, and a stop signal at codon 182 within the S gene, respectively) was performed. HBV infecting 14 (35%) patients had single or multiple preS/S genomic mutations (i.e., preS1 and/or preS2 deletions, preS2 start codon mutations, C-terminally truncated and/or “a” determinant mutated S protein). Presence of preS/S variants negatively correlated with HBsAg titers ( r = −0.431; P = 0.005) and its prevalence did not significantly differ between HBeAg-positive and HBeAg-negative patients. No correlation was found between HBsAg and HBV DNA levels in patients infected with preS/S mutants, whereas a significant correlation was found between HBsAg and viremia levels ( r = 0.607; P = 0.001) in patients infected with wild-type HBV strains. HepG2 cells replicating the above-mentioned three preS/S variants showed significant reduction of HBsAg secretion, retention of envelope proteins in the endoplasmic reticulum, less efficient virion secretion and nuclear accumulation of significantly higher amounts of covalently closed circular DNA compared with wild-type HBV replicating cells. Conclusion: In patients infected with preS/S variants, HBV DNA replication and HBsAg synthesis/secretion appear to be dissociated. Therefore, the use of HBsAg titer as diagnostic/prognostic tool has to take into account the frequent emergence of preS/S variants in chronic HBV infection. (HEPATOLOGY 2012;)Keywords
This publication has 37 references indexed in Scilit:
- Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A reviewHepatology, 2011
- Hepatitis B surface antigen monitoring and management of chronic hepatitis BJournal of Viral Hepatitis, 2011
- Replicative and Transcriptional Activities of Hepatitis B Virus in Patients Coinfected with Hepatitis B and Hepatitis Delta VirusesJournal of Virology, 2011
- Profile of pre‐S deletions in the natural history of chronic hepatitis B infectionJournal of Medical Virology, 2010
- Drastic Reduction in the Production of Subviral Particles Does Not Impair Hepatitis B Virus Virion SecretionJournal of Virology, 2009
- Hepatitis B virus pre-S deletion mutations are a risk factor for hepatocellular carcinoma: a matched nested case–control studyJournal of General Virology, 2008
- Characterization of the Intracellular Deproteinized Relaxed Circular DNA of Hepatitis B Virus: an Intermediate of Covalently Closed Circular DNA FormationJournal of Virology, 2007
- Mutations affecting the replication capacity of the hepatitis B virusJournal of Viral Hepatitis, 2006
- Modulation of Hepatitis B Virus Secretion by Naturally Occurring Mutations in the S GeneJournal of Virology, 2004
- Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseasesJournal of Hepatology, 2004